{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T21:22:09Z","timestamp":1780435329351,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.05.077","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T03:33:24Z","timestamp":1498016004000},"page":"4002-4009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts\u2019 children to relatively low invasiveness"],"prefix":"10.1016","volume":"35","author":[{"given":"I.","family":"Yildirim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Finkelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.P.","family":"Hanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.I.","family":"Pelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9966","key":"10.1016\/j.vaccine.2017.05.077_b0005","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(14)61698-6","article-title":"Global, regional, and national causes of child mortality in 2000\u201313, with projections to inform post-2015 priorities: an updated systematic analysis","volume":"385","author":"Liu","year":"2015","journal-title":"Lancet"},{"issue":"9693","key":"10.1016\/j.vaccine.2017.05.077_b0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.vaccine.2017.05.077_b0015","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.vaccine.2014.03.054","article-title":"Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001\u20132013","volume":"32","author":"Guevara","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.077_b0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.077_b0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.idc.2015.07.009","article-title":"Pneumococcal disease in the era of pneumococcal conjugate vaccine","volume":"29","author":"Yildirim","year":"2015","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.077_b0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.077_b0035","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/infdis\/jiu576","article-title":"Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae","volume":"211","author":"Dagan","year":"2015","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.077_b0040","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.1542\/peds.2004-2338","article-title":"Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004","volume":"116","author":"Huang","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.077_b0045","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jpids\/pit057","article-title":"Impact of 13-valent pneumococcal conjugate vaccination on streptococcus pneumoniae carriage in young children in massachusetts","volume":"3","author":"Lee","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.077_b0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.vaccine.2010.10.032","article-title":"Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease","volume":"29","author":"Yildirim","year":"2010","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.05.077_b0055","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1086\/374624","article-title":"Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential","volume":"187","author":"Brueggemann","year":"2003","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.077_b0060","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1086\/423820","article-title":"Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children","volume":"190","author":"Brueggemann","year":"2004","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.077_b0065","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/01.inf.0000220231.79968.f6","article-title":"Site-specific disease potential of individual Streptococcus pneumoniae serotypes in pediatric invasive disease, acute otitis media and acute conjunctivitis","volume":"25","author":"Shouval","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.077_b0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.epidem.2010.03.005","article-title":"Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete","volume":"2","author":"Hanage","year":"2010","journal-title":"Epidemics"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.077_b0075","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1542\/peds.2014-0473","article-title":"Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine","volume":"134","author":"Iroh Tam","year":"2014","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.077_b0080","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1542\/peds.2014-2426","article-title":"Members of the Massachusetts Department of Public H. Vaccination, underlying comorbidities, and risk of invasive pneumococcal disease","volume":"135","author":"Yildirim","year":"2015","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.077_b0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.2008-3099","article-title":"Continued impact of pneumococcal conjugate vaccine on carriage in young children","volume":"124","author":"Huang","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2017.05.077_b0090","unstructured":"http:\/\/www.cdc.gov\/vaccines\/imz-managers\/nis\/data-tables.html. [accessed February 2nd, 2017]."},{"issue":"8","key":"10.1016\/j.vaccine.2017.05.077_b0095","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1128\/JCM.02498-06","article-title":"Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA","volume":"45","author":"Carvalho Mda","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.077_b0100","series-title":"Encylclopedia of biostatistics","author":"Armitage","year":"2005"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.077_b0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","article-title":"Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.077_b0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","article-title":"The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II","volume":"30","author":"Hausdorff","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2017.05.077_b0115","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/381686","article-title":"Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae","volume":"189","author":"Sandgren","year":"2004","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.077_b0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/INF.0b013e3181f87802","article-title":"Nasopharyngeal carriage of individual Streptococcus pneumoniae serotypes during pediatric pneumonia as a means to estimate serotype disease potential","volume":"30","author":"Greenberg","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.077_b0125","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JCM.01763-10","article-title":"Analysis of invasiveness of pneumococcal serotypes and clones circulating in Portugal before widespread use of conjugate vaccines reveals heterogeneous behavior of clones expressing the same serotype","volume":"49","author":"Sa-Leao","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.05.077_b0130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/infdis\/jit481","article-title":"Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children","volume":"209","author":"Browall","year":"2014","journal-title":"J Infect Dis"},{"issue":"Suppl. 435","key":"10.1016\/j.vaccine.2017.05.077_b0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1651-2227.2000.tb00775.x","article-title":"Epidemiology of invasive pneumococcal infections in children aged 0-6 years in Denmark: a 19-year nationwide surveillance study","volume":"89","author":"Kaltoft","year":"2000","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2017.05.077_b0140","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(05)70083-9","article-title":"Epidemiological differences among pneumococcal serotypes","volume":"5","author":"Hausdorff","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"282","key":"10.1016\/j.vaccine.2017.05.077_b0145","first-page":"20143085","article-title":"Evolution of the immune system in humans from infancy to old age","volume":"2015","author":"Simon","year":"1821","journal-title":"Proc Biol Sci"},{"issue":"46","key":"10.1016\/j.vaccine.2017.05.077_b0150","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","article-title":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children","volume":"33","author":"Varon","year":"2015","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.05.077_b0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/1469-0691.12422","article-title":"High invasiveness of pneumococcal serotypes included in the new generation of conjugate vaccines","volume":"20","author":"Del Amo","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.vaccine.2017.05.077_b0160","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1128\/IAI.73.1.431-435.2005","article-title":"Invasiveness of serotypes and clones of Streptococcus pneumoniae among children in Finland","volume":"73","author":"Hanage","year":"2005","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2017.05.077_b0165","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/INF.0000000000001037","article-title":"Epidemiology of invasive pneumococcal disease in Bangladeshi children before introduction of pneumococcal conjugate vaccine","volume":"35","author":"Saha","year":"2016","journal-title":"Pediatr Infect Dis J"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T12:24:42Z","timestamp":1535718282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":33,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17307363"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts\u2019 children to relatively low invasiveness","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}